Hologic (HOLX) Wins Appeal on Patent Validity for SenoRx Case; Invalid Ruling Reversed

February 24, 2011 11:17 AM EST Send to a Friend
Bloomberg reporting that Hologic (Nasdaq: HOLX) has won an appeal on patent validity in its SenoRx case.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Litigation

Add Your Comment